8-K/A: Longevity Health Holdings Completes Acquisition of Skincare Business from PMGC Holdings

Longevity Health Holdings finalizes the acquisition of PMGC Holdings' skincare business, aiming to expand its market presence.

Summary

• Longevity Health Holdings, formerly Carmell Corporation, has completed the acquisition of substantially all assets and assumption of certain liabilities of PMGC Holdings Inc. and Elevai Skincare, Inc.'s skincare and haircare business on January 16, 2025.
• The purchase consideration included 1,149,226 shares of Longevity Health Holdings' common stock, assumption of certain liabilities, and $56,525 in cash contingent on the sale of specific inventory.
• Additional earnout consideration includes royalties of 5% of net sales from existing products over five years and a one-time payment of $500,000 if net revenue from hair and scalp products reaches $500,000 within two years.
• The unaudited pro forma combined financial information illustrates the effect of the acquisition, with adjustments made to historical financial statements.
• The skincare business's unaudited interim financial statements as of September 30, 2024, show revenue of $1,747,570 and a net loss of $2,012,113 for the nine-month period.
• The audited financial statements for the year ended December 31, 2023, reveal revenue of $1,712,595 and a net loss of $2,644,778.
• The acquisition aims to enhance Longevity Health Holdings' market position in the skincare and haircare sector.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While the acquisition itself is a positive step for growth, the acquired business has a history of losses and faces regulatory challenges, resulting in a neutral to slightly negative sentiment.

Positives

• The acquisition provides Longevity Health Holdings with an established skincare and haircare business.
• Potential for future revenue growth through earnout payments tied to sales performance.
• The pro forma financial information provides transparency into the combined financial position of the company.

Negatives

• The skincare business has a history of net losses, with a $2,012,113 loss for the nine months ended September 30, 2024, and a $2,644,778 loss for the year ended December 31, 2023.
• The company's auditors report contains an emphasis of matter paragraph describing an uncertainty about the Skincare Business ability to continue as a going concern.
• The company had a net working capital deficit of $29,586 as of December 31, 2023.

Risks

• The skincare business's history of losses raises concerns about its future profitability.
• The success of the acquisition depends on integrating the acquired business and achieving synergies.
• The earnout payments are contingent on future sales performance, which may not be guaranteed.
• Health Canada has raised regulatory concerns about the business's products.

Future Outlook

The future outlook depends on the successful integration of the acquired business and the achievement of sales targets to trigger earnout payments. The company is also obligated to pay the Royalties, which will be recognized as incurred.

Industry Context

The acquisition reflects a trend of consolidation in the skincare and haircare industry, with companies seeking to expand their product portfolios and market reach through strategic acquisitions.

Comparison to Industry Standards

• Without specific details on the products, market positioning, and competitive landscape, it's challenging to provide a precise comparison to industry standards.
• However, the financial performance of the acquired skincare business, particularly its net losses, would likely be a concern compared to industry benchmarks for profitability.
• Comparable companies in the skincare industry include Estée Lauder, L'Oréal, and Unilever, which typically have higher profit margins and stronger financial performance.
• The success of the acquisition will depend on Longevity Health Holdings' ability to improve the financial performance of the acquired business and achieve synergies.

Management Changes

Legal Proceedings

• The Business received correspondence from Health Canada, advising that Health Canada had reviewed certain undisclosed information about the Business’s products.
• Health Canada advised that based on this review, the products did not meet Health Canada’s interpretation of the conditions required to market a cosmetic in Canada.
• Depending on the outcome of the Business’s engagement with Health Canada, the Business’s products could be subject to additional regulatory requirements in order to be advertised or sold in Canada.

Related Party Transactions

• Historically, the Business has been managed and operated in the ordinary course of business within the Parent.
• Certain costs have been allocated to Skincare and reflected as expenses in the Financial Statements.
• Treasury activities, including activities related to the Business, are centralized by the Parent such that net cash collections and disbursements are generally distributed to the Parent and reflected as net Parent investment.
• As of September 30, 2024, the Business owed Jordan Plews, Director, $60,539 in accrued salaries.

Stakeholder Impact

• Shareholders of Longevity Health Holdings will see a change in the company's business focus with the addition of the skincare business.
• Employees of the acquired business may experience changes in their roles and responsibilities.
• Customers of the skincare business may see changes in product offerings and distribution channels.
• Suppliers to the skincare business may be affected by changes in purchasing patterns.

Next Steps

• Integrate the acquired skincare business into Longevity Health Holdings' operations.
• Achieve sales targets to trigger earnout payments.
• Address regulatory concerns raised by Health Canada.
• Finalize the valuation work necessary to arrive at the final fair values of the assets acquired and liabilities assumed.

Key Dates

Keywords

acquisition, skincare, haircare, financial statements, pro forma, Longevity Health Holdings, PMGC Holdings, Elevai Skincare, merger